Doctor profile · Federal record
Dr. Thomas Urice, M.D.
Specialist (CMS: Dermatology) · Norman, OK
- NPI 1023016169
- Accepts Medicare
- MIPS 7.5 / 100 · 2023
- 48 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2413 Palmer Cir
Norman, OK 730696301
(405) 321-5322
fax (405) 321-5348
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- May 13, 2014
- Year of graduation
- 1978 — 48 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Oklahoma #13255
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023016169. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,595
Distinct HCPCS
10
Medicare allowed
$611,406
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,762 | 1,923 | $84 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,099 | 517 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,195 | 827 | $47 | |
17110 |
Destruction of skin growth, 1-14 growths | 1,091 | 892 | $101 | |
11102 |
Biopsy of related skin growth, first growth | 732 | 587 | $83 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 704 | 588 | $52 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 177 | 120 | $117 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 166 | 166 | $103 | |
11103 |
Biopsy of related skin growth, each additional growth | 115 | 91 | $46 | |
10040 |
Acne surgery | 84 | 79 | $105 |
In context: peer comparison
Among 3 peers in Norman Specialist, average services per provider: 406. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$2,194
Transactions
127
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 16 | $368.75 | |
| Lilly USA, LLC | 17 | $293.52 | |
| Arcutis Biotherapeutics, INC. | 17 | $245.60 | |
| Janssen Biotech, INC. | 9 | $207.06 | |
| Ucb, INC. | 16 | $199.62 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $165.59 | |
| Leo Pharma INC. | 12 | $153.61 | |
| Novartis Pharmaceuticals Corporation | 13 | $146.62 | |
| Regeneron Healthcare Solutions, INC. | 5 | $142.02 | |
| Pfizer INC. | 4 | $74.36 | |
| Sun Pharmaceutical Industries INC. | 3 | $65.07 | |
| Amgen INC. | 3 | $41.56 | |
| Abbvie INC. | 2 | $30.97 | |
| Kyowa Kirin, INC. | 1 | $23.50 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $14.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,485
Patients
891
Total drug cost
$180,601
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 371 | 244 | $3,103 |
| Hydrocortisone | Generic | 227 | 174 | $3,345 |
| Clobetasol Propionate | Generic | 168 | 120 | $7,528 |
| Doxycycline Hyclate | Generic | 145 | 55 | $3,785 |
| Metronidazole | Generic | 122 | 71 | $8,590 |
| Hydroxyzine Hcl | Generic | 82 | 36 | $1,674 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 65 | 34 | $1,509 |
| Clindamycin Phosphate | Generic | 46 | 23 | $1,363 |
| Fluocinonide | Generic | 46 | 40 | $1,799 |
| Tretinoin | Generic | 40 | 16 | $3,202 |
Hospital affiliations
Frequently asked questions
What is Dr. Thomas Urice's medical specialty?
Dr. Thomas Urice practices Specialist in Norman, OK.
Where does Dr. Thomas Urice practice?
Dr. Thomas Urice practices at 2413 Palmer Cir, Norman, OK 730696301. Office phone: 4053215322.
What is Dr. Thomas Urice's NPI?
Dr. Thomas Urice's National Provider Identifier (NPI) is 1023016169, issued by NPPES.
Does Dr. Thomas Urice accept Medicare assignment?
Yes. Dr. Thomas Urice accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Thomas Urice commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.